Major patents on blockbuster drugs continue to expire. Each drug requires huge investment and many years of R&D before marketing. How can return-on-investment be maximised?
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
The Drug Price Competition and Patent Term Restoration Act 1984 (known as the “Hatch–Waxman Act”).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
French, H. Maximizing exclusivity for drug products. Nat Rev Drug Discov 4, 709 (2005). https://doi.org/10.1038/nrd1829
Issue date:
DOI: https://doi.org/10.1038/nrd1829
This article is cited by
-
Market Exclusivity Strategies for Pharmaceuticals
Pharmaceutical Medicine (2009)
